Bullish on Bristol Myers Squibb
Update 9/27/2024: Cobenfy (formerly KarXT) was Approved by the FDA. 1st Schizophrenia drug in a long time, and the 1st that doesn’t block Dopamine. Which is a common reason people … Read More
Featured
Tag: FDA
Featured
GlaxoSmithKline Cancer Drug Jemperli GSK
GSK’s Jemperli: Awaitng FDA Decision on Expanding Treatment Options. GlaxoSmithKline (GSK)’s immunotherapy drug, Jemperli, is currently under review by the FDA for potential approval in additional cancer indications. The drug … Read More
